Viewing Study NCT02454933


Ignite Creation Date: 2025-12-25 @ 2:50 AM
Ignite Modification Date: 2025-12-31 @ 2:56 PM
Study NCT ID: NCT02454933
Status: COMPLETED
Last Update Posted: 2024-09-19
First Post: 2015-05-14
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Study of AZD9291 Plus MEDI4736 Versus AZD9291 Monotherapy in NSCLC After Previous EGFR TKI Therapy in T790M Mutation Positive Tumours
Sponsor: AstraZeneca
Organization: